Compression Bandaging and Manual Lymph Drainage in Women With Lymphedema
LYMPHATIC
Effectiveness of the Combination of Compression Bandaging and Manual Lymph Drainage in Women With Secondary Lymphedema After Breast Cancer.
2 other identifiers
interventional
44
1 country
1
Brief Summary
Lymphedema is the result of accumulation of fluid and other elements in tissue spaces because of an imbalance between the production of fluid interstitial and transport. Lymphedema can cause significant physical and psychological morbidity. Prevalence of lymphedema in patients after breast cancer surgery is 12-60% and the incidence is 12-26%.Psychological and social consequences of secondary lymphedema related breast cancer have been little recognized and documented. Although, it have performed many studies related secondary lymphedema it not found sufficient evidence in the literature to suggest the most effective treatment. There is some evidence suggesting that compression therapy and manual lymphatic drainage can improve lymphedema but more studies are needed. The aim of this research is to to evaluate the clinical effect of multimodal treatment (compression bandaging and manual lymph drainage) versus applying manual lymphatic drainage in women with arm lymphedema after breast cancer surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2014
CompletedFirst Posted
Study publicly available on registry
June 17, 2014
CompletedStudy Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedJune 17, 2014
June 1, 2014
1.2 years
June 13, 2014
June 13, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Perimetry
Arm volume is measured with perimetry through truncation of cones formula
Baseline, 6 weeks and 12 weeks
Secondary Outcomes (14)
Handgrip strength
Baseline, 6 weeks and 12 weeks
Multiple sit-to-stant test
Baseline, 6 weeks and 12 weeks
Degree of pain
Baseline, 6 weeks and 12 weeks
Pulmonary function test
Baseline, 6 weeks and 12 weeks
Maximal inspiratory pressures (MIP) and maximal expiratory pressures (MEP)
Baseline, 6 weeks and 12 weeks
- +9 more secondary outcomes
Study Arms (2)
Manual lymphatic drainage and compression bandaging
EXPERIMENTALExperimental group: 30 minutes and one hour maximum time of manual lymphatic drainage and compression bandaging with multilayer inelastic bandages with low extensibility. It is possible to apply bandages two or three times per week. Also, an elastic bandage is also held in hand fingers with slight compression and other protective bandage is used in skin. The treatment will be carried out for six weeks five days a week
Manual lymphatic drainage
ACTIVE COMPARATORControl group: 30 minutes and one hour maximum time of manual lymphatic drainage. The treatment will be carried out for six weeks five days a week.
Interventions
30 minutes and one hour maximum time of manual lymphatic drainage and compression bandaging with multilayer inelastic bandages with low extensibility. It is possible to apply bandages two or three times per week. Also, an elastic bandage is also held in hand fingers with slight compression and other protective bandage is used in skin. The treatment will be carried out for six weeks five days a week
30 minutes and one hour maximum time of manual lymphatic drainage. The treatment will be carried out for six weeks five days a week.
Eligibility Criteria
You may qualify if:
- Women between 45 and 65 years with secondary lymphedema in upper limb after breast cancer surgery.
- Cancer stages I-III according to TNM classification of the American Joint Committee on Cancer.
You may not qualify if:
- To have received lymphedema treatment previously.
- To be treated by radiation therapy or chemotherapy.
- Distant metastases or local recurrence of cancer.
- Infectious signs in the upper limb with lymphedema.
- Uncontrolled hypertension.
- Heart disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Málaga
Málaga, Málaga, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph D
Study Record Dates
First Submitted
June 13, 2014
First Posted
June 17, 2014
Study Start
September 1, 2014
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
June 17, 2014
Record last verified: 2014-06